臺灣健保癌症用藥事前審查實作指引
1.0.8 - ci-build
臺灣健保癌症用藥事前審查實作指引
1.0.8 - ci-build
臺灣健保癌症用藥事前審查實作指引, published by 衛生福利部中央健康保險署. This guide is not an authorized publication; it is the continuous build for version 1.0.8 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/TWNHIFHIR/pas/ and changes regularly. See the Directory of published versions
| Official URL: https://nhicore.nhi.gov.tw/pas/CodeSystem/inca-osiris | Version: 1.0.8 | |||
| Active as of 2025-10-01 | Computable Name: INCaOsiris | |||
INCa-健保事前審查-基因突變類型，資料所屬單位：Institut National du Cancer (INCa)，參照至：https://github.com/InstitutNationalduCancer/OSIRIS。
This Code system is referenced in the content logical definition of the following value sets: